Want to see IN:AJOONI full AI Analyst Report?
Top Page
Ajooni Biotech Limited
(AJOONI)
Select Model
Select Model
Rating:55Neutral
Price Target:
₹3.50
▼(-31.77% Downside)
Action:Reiterated
Date:07/16/26
The score is held back primarily by weak cash flow quality (multi-year negative operating cash flow and worsening free cash flow) despite strong revenue growth and a still-conservative balance sheet. Technicals are moderately supportive in the near term but not strong enough to offset the cash burn risk, while valuation is reasonable with a mid-teens P/E and no dividend yield support.
Positive Factors
Strong Revenue Growth
Accelerating revenue growth indicates improving scale and stronger demand for the company’s animal health and nutrition products. If sustained, broader sales can support operating leverage, expand distribution reach, and create a larger base from which to build future earnings and cash generation.
Negative Factors
Persistent Cash Burn
Repeated negative operating cash flow means reported earnings have not consistently converted into cash, while worsening free cash flow increases dependence on financing or balance-sheet resources. Unless cash conversion improves, growth may remain funding-intensive and execution flexibility could narrow.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
Accelerating revenue growth indicates improving scale and stronger demand for the company’s animal health and nutrition products. If sustained, broader sales can support operating leverage, expand distribution reach, and create a larger base from which to build future earnings and cash generation.
Read all positive factors
Ajooni Biotech Limited (AJOONI) vs. iShares MSCI India ETF (INDA)
Market Cap
₹602.85M
Dividend YieldN/A
Average Volume (3M)326.08K
Price to Earnings (P/E)15.4
Beta (1Y)1.05
Revenue Growth78.39%
EPS Growth15.76%
CountryIN
Employees109
SectorGeneral
Sector StrengthN/A
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.22
Shares Outstanding172,243,590
10 Day Avg. Volume394,413
30 Day Avg. Volume326,084
Financial Highlights & Ratios
PEG Ratio-0.85
Price to Book (P/B)2.02
Price to Sales (P/S)1.01
P/FCF Ratio-7.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Ajooni Biotech Limited Business Overview & Revenue Model
Company Description
Founded in 2010, Ajooni Biotech Limited is an Indian enterprise primarily engaged in the production and distribution of animal nutrition products. Headquartered in Mohali, India, the company's offerings encompass specialized cattle feeds and vario...
How the Company Makes Money
Ajooni Biotech Limited primarily makes money by selling animal health and nutrition products (and related livestock/poultry-focused inputs) through its sales and distribution channels to customers in the animal husbandry ecosystem (e.g., farms, di...
Ajooni Biotech Limited Financial Statement Overview
Summary
Income Statement
73
Positive
Balance Sheet
78
Positive
Cash Flow
22
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.15B | 1.82B | 1.15B | 801.15M | 744.88M | 740.38M |
| Gross Profit | 303.98M | 276.71M | 138.13M | 97.65M | 87.45M | 100.24M |
| EBITDA | 76.80M | 62.56M | 57.57M | 44.27M | 30.60M | 31.12M |
| Net Income | 39.59M | 43.22M | 32.38M | 21.61M | 11.25M | 10.49M |
Balance Sheet | ||||||
| Total Assets | 1.25B | 1.20B | 950.51M | 475.20M | 587.31M | 290.18M |
| Cash, Cash Equivalents and Short-Term Investments | 3.74M | 4.19M | 68.30M | 4.30M | 4.93M | 573.86K |
| Total Debt | 269.11M | 177.63M | 19.40M | 21.68M | 51.77M | 53.50M |
| Total Liabilities | 332.86M | 291.74M | 69.72M | 48.12M | 170.62M | 126.35M |
| Stockholders Equity | 916.23M | 911.91M | 880.79M | 427.08M | 416.69M | 163.82M |
Cash Flow | ||||||
| Free Cash Flow | 18.31M | -232.32M | -192.16M | -95.54M | -84.39M | 15.60M |
| Operating Cash Flow | 135.46M | -52.03M | -171.84M | -39.52M | -55.79M | 36.84M |
| Investing Cash Flow | -122.77M | -170.31M | -171.34M | 76.37M | -158.24M | -18.97M |
| Financing Cash Flow | 71.88M | 158.23M | 248.26M | -35.66M | 216.55M | -19.73M |
Ajooni Biotech Limited Technical Analysis
Negative
5.13
Price Trends
3.83
Negative
3.93
Negative
4.15
Negative
Market Momentum
-0.10
Positive
34.77
Neutral
16.95
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:AJOONI, the sentiment is Negative. The current price of 5.13 is above the 20-day moving average (MA) of 3.69, above the 50-day MA of 3.83, and above the 200-day MA of 4.15, indicating a bearish trend. The MACD of -0.10 indicates Positive momentum. The RSI at 34.77 is Neutral, neither overbought nor oversold. The STOCH value of 16.95 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:AJOONI.
Ajooni Biotech Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | ₹111.07B | 19.96 | ― | 1.25% | 11.35% | -8.27% | |
60 Neutral | ₹13.04B | 11.41 | ― | 0.52% | 39.75% | 186.91% | |
56 Neutral | ₹9.12B | 13.93 | ― | ― | 76.01% | 59.13% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
55 Neutral | ₹602.85M | 15.43 | ― | ― | 78.39% | 15.76% | |
53 Neutral | ₹33.23B | 25.47 | ― | 0.37% | 10.91% | 3.74% | |
47 Neutral | ₹1.51B | 31.71 | ― | ― | 17.76% | -50.16% |
* General Sector Average
IN:AJOONI
Ajooni Biotech Limited
3.47
-1.68
-32.62%
IN:AVANTIFEED
Avanti Feeds Limited
799.05
92.36
13.07%
IN:MKPL
M K Proteins Limited
4.02
-3.21
-44.40%
IN:MUKKA
Mukka Proteins Limited
32.07
4.51
16.36%
IN:PARAGMILK
Parag Milk Foods Ltd.
269.00
-8.40
-3.03%
IN:SKMEGGPROD
SKM Egg Products Export (India) Ltd.
241.35
70.89
41.59%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.